← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (636)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (3132)

• Molecular Biological Mechanisms of Action of Chrysophanol in Hepatic Stellate Cells Activated by Hepatic B Virus X Based on Network Pharmacology. (2024/01/01) ♡
• Hospital Utilization for Patients With Cirrhosis and Severe Ascites in a Model of Outpatient Paracentesis by Interventional Radiology. (2023/12/31) ♡
• Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention. (2023/12/31) ♡
• The Detection of Primary Sclerosing Cholangitis Using Volatile Metabolites in Fecal Headspace and Exhaled Breath. (2023/12/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure? (2023/12/29) ♡
• Experimental In Vivo Toxicity Models for Alcohol Toxicity. (2023/12/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link. (2023/12/28) ♡
• SPP2 plays a role in the tumorigenesis of hepatocellular carcinoma: A bioinformatic based analysis. (2023/12/28) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis. (2023/12/27) ♡
• Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked. (2023/12/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease? (2023/12/25) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hydroalcoholic extract of Scrophularia striata has a significant therapeutic effect on thioacetamide-induced liver cirrhosis in rats. (2023/12/22) ♡
• [Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C]. (2023/12/22) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: Case report: Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) presenting with liver cirrhosis and steroid-responsive interstitial pneumonia. (2023/12/22) ♡
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study. (2023/12/22) ♡
• Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH). (2023/12/21) ♡
• Identification and validation of key biomarkers associated with macrophages in nonalcoholic fatty liver disease based on hdWGCNA and machine learning. (2023/12/21) ♡
• Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. (2023/12/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities. (2023/12/21) ♡
• A Novel Score-Based Approach by Using Routine Laboratory Tests for Accurate Diagnosis of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotic Patients. (2023/12/21) ♡
• [Progress in the treatment of sarcopenia in patients with cirrhosis]. (2023/12/20) ♡
• Determination of ertapenem in plasma and ascitic fluid by UHPLC-MS/MS in cirrhotic patients with spontaneous bacterial peritonitis. (2023/12/20) ♡
• Expert opinion on bleeding risk from invasive procedures in cirrhosis. (2023/12/19) ♡
• Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list. (2023/12/19) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9. (2023/12/15) ♡
• Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study. (2023/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management. (2023/12/14) ♡
• Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study. (2023/12/13) ♡
• Assessing the risk factors associated with sarcopenia in patients with liver cirrhosis: a case-control study. (2023/12/09) ♡
• [Infant glycogen storage disease type Ⅳ: a clinicopathological and genetic characteristics analysis of five cases]. (2023/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Comprehensive Review on Non-Alcoholic Fatty Liver Disease. (2023/12/08) ♡
• Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance. (2023/12/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. TFR2-Related Hemochromatosis. (2023/12/07) ♡
• Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity. (2023/12/07) ♡
• Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study. (2023/12/07) ♡
• Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease. (2023/12/07) ♡
• Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease. (2023/12/06) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans. (2023/12/05) ♡
• Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018. (2023/12/05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. (2023/12/02) ♡
• The contributions of bacteria metabolites to the development of hepatic encephalopathy. (2023/12/01) ♡
• UPLC-Q-TOF-MS based investigation into the bioactive compounds and molecular mechanisms of Lamiophlomis Herba against hepatic fibrosis. (2023/12/01) ♡
• Portal-hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy. (2023/12/01) ♡
• Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nasoenteric Tube Placement in Patients with Esophageal Varices: A Review of the Current Evidence and Society Guidelines. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Osmotic Demyelination Syndrome in a High-Risk Patient Despite Cautious Correction of Hyponatremia. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute haemorrhagic necrotizing encephalopathy associated with COVID-19 in a patient with liver cirrhosis. (2023/12/01) ♡
• Hepatoprotective Effect of Moringa Oil on Rats under Fungicide Toxicity. (2023/12/01) ♡
• Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens. (2023/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.